Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Isracann Biosciences Inc. (ISCNF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0116-0.0021 (-15.20%)
At close: 03:48PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0137
Open0.0116
BidN/A x N/A
AskN/A x N/A
Day's Range0.0116 - 0.0129
52 Week Range0.0090 - 0.1400
Volume138,242
Avg. Volume208,913
Market Cap2.041M
Beta (5Y Monthly)-0.24
PE Ratio (TTM)N/A
EPS (TTM)-0.1410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Isracann Biosciences Provides Bi-Weekly Default Status Report

    VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that further to its news release dated September 29, 2022 (the “Default Announcement”), the Company’s principal regulator, the British Columbia Securities Commission (the “BCSC”) granted a management cease trade order (the “MCTO”) on September 29, 2022, under National Policy 12-203 Management Cease Trade Orders (“NP 12-203”). Pursuant to the M

  • GlobeNewswire

    Isracann Biosciences Announces Delay in Filing Annual Financial Statements

    VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) announces that the filing of its audited annual financial statements for the year ended May 31, 2022, including the related management discussion and analysis, and CEO and CFO certifications (collectively, the “Annual Financial Filings”) were not filed by the required filing deadline of September 28, 2022 (the “Filing Deadline”). The Annual Financial F

  • GlobeNewswire

    Isracann Bioscience Facilitated Genetics Arrive in Israel

    Partner Facility Now Growing Canadian Cannabis StrainsVANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a multi-faceted Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor is pleased to announce that previously shipped genetics have cleared Israeli customs and are being raised as mother stock. “The Israeli market will now have access to premium Canad

Advertisement
Advertisement